BELVIQ¿ — Class III drug recall D-0302-2015
Terminated recall by Eisai Inc, reported 2014-12-24, distributed nationwide. Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot nu
| Recall number | D-0302-2015 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eisai Inc, Research Triangle Park, NC, United States |
| Recall initiated | 2014-12-05 |
| Classified | 2014-12-16 |
| Reported by FDA | 2014-12-24 |
| Terminated | 2015-05-21 |
| Distributed | Nationwide (US) |
| Quantity | 121,680 bottles |
| Reason classes | labeling |
| Lot numbers | 11/15, 12/15, 13297008, 13307008, 13367008 |
Product
BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.
Reason for recall
Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0302-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.